First Analysis Initiates Coverage on ArcSight (ARST) with an Overweight
More News related to ARST
- ArcSight to Report Fiscal First Quarter 2009 Financial Results
- ArcSight (ARST) Joins the McAfee (MFE) Security Innovation Alliance(TM)
- McAfee and ArcSight Partner to Provide Powerful Workflow Capabilities for Security and Compliance Monitoring
- ArcSight Announces All-in-One PCI Log Management Appliance Optimized for Channel Partners
- New ArcSight Logger Adds Real-Time Analysis and Event Mining to Reduce Investigation Time, Effort, and Cost
More News related to New Coverage
- Morgan Stanley Resumes Coverage of Covidien (COV), Baxter (BAX), Becton Dickinson (BDX), Hospira (HSP), Integra (IART)
- Morgan Stanley Starts Waters Corp. (WAT) at Overweight
- Morgan Stanley Starts Illumina (ILMN) at Overweight
- Morgan Stanley Resumes Abbott Labs (ABT) at Overweight
- Sidoti Starts LaBarge (LB) at Buy
First Analysis initiates coverage on ArcSight (Nasdaq: ARST) with an Overweight. Price target $14.
ArcSight, Inc. (ArcSight) is a provider of security and compliance management solutions that mitigate business risk for enterprises and government agencies.
Related Categories
New CoverageStocks Mentioned
+0.00Related Entities
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
